M. Woods et al., Efficacy of the beta 3-adrenergic receptor agonist CL-316243 on experimental bladder hyperreflexia and detrusor instability in the rat, J UROL, 166(3), 2001, pp. 1142-1147
Purpose: Recent evidence indicates that in a number of species detrusor rel
axation is mediated through activation of the beta3-adrenergic receptor. We
determined whether activation of the beta3-adrenergic receptor would be a
useful therapeutic approach for bladder instability. We profiled in vitro a
ctivity of the beta3-adrenergic receptor agonist CL-616243 and the efficacy
of this compound in experimental models of detrusor instability and bladde
r hyperreflexia.
Materials and Methods: Isolated rat detrusor strips were contracted by depo
larizing the preparations with 20 mM. KCl. CL-316423 was added to the tissu
e bath in increasing concentrations and contraction inhibition was assessed
. Efficacy against bladder instability was evaluated using the obstructed h
ypertrophied bladder model in the rat. The acetic acid bladder cystometry m
odel was used to assess the efficacy of CL-316423 in bladder hyperreflexia.
Isovolumetric contractions were evoked by electrical stimulation using a s
ilver bipolar electrode. Data are expressed as the mean plus or minus stand
ard error of mean.
Results: CL-316243 inhibited spontaneously contracting, isolated rat detrus
or strips in a concentration dependent manner with a mean concentration inh
ibiting 50% of maximal response of 2.65 +/- 0.36 nM. Intrinsic activity rel
ative to forskolin was 1. In vivo CL-316243 administered intravenously or o
rally significantly increased the voiding interval and bladder compliance.
In addition, there was a decrease in the number of spontaneous contractions
during the filling phase in a model of neurogenic and obstruction induced
bladder instability. The amplitude of electrically evoked isovolumetric con
tractions was significantly smaller after CL-316243 exposure.
Conclusions: These data suggest that activating the beta3-adrenergic recept
or in rat bladder using CL-316243 may directly inhibit smooth muscle contra
ctility, experimental hyperreflexia and detrusor instability, and be useful
for urge urinary incontinence.